ID: ALA4390738
Type: Binding
Description: Inhibition of recombinant human N-terminal His-tagged PDI expressed in Escherichia coli BL21 (DE3) pLysS assessed as reduction in enzyme-mediated bovine insulin aggregation
Organism: Homo sapiens
Bioactivity
Activity Types for Assay ALA4390738
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
292.26 | 4.31 | 4.31 |
254.28 | 3.30 | 3.30 |
240.26 | 2.99 | 2.99 |
240.26 | 2.99 | 2.99 |
263.30 | 3.46 | 3.46 |
263.30 | 3.46 | 3.46 |
293.32 | 3.47 | 3.47 |
292.26 | 4.31 | 4.31 |
240.26 | 2.99 | 2.99 |
292.26 | 4.31 | 4.31 |
267.26 | 3.30 | 3.30 |
252.08 | ||
316.40 | 4.44 | 4.44 |
452.44 | 3.99 | 3.99 |
312.35 | 2.10 | 2.10 |
297.27 | 3.19 | 3.19 |
301.35 | 4.35 | 4.35 |
396.51 | 4.27 | 4.27 |
267.26 | 3.30 | 3.30 |
267.26 | 3.30 | 3.30 |
279.30 | 3.17 | 3.17 |
312.32 | 3.08 | 3.08 |
249.27 | 3.16 | 3.16 |
452.62 | 5.83 | 5.83 |
248.28 | 3.04 | 3.04 |
388.45 | 4.26 | 4.26 |
385.47 | 4.15 | 4.15 |
286.26 | 3.13 | 3.13 |
433.45 | 4.16 | 4.16 |
301.35 | 4.35 | 4.35 |
399.49 | 4.45 | 4.45 |
364.42 | 4.87 | 4.87 |
268.27 | 2.99 | 2.99 |
443.61 | 5.66 | 5.66 |
317.27 | 4.18 | 4.18 |
318.38 | 3.29 | 3.29 |
279.30 | 3.17 | 3.17 |
375.22 | 3.62 | 3.62 |
340.38 | 4.63 | 4.63 |
267.28 | 2.86 | 2.86 |
282.30 | 3.07 | 3.07 |
235.25 | 2.24 | 2.24 |
334.22 | ||
277.09 | ||
267.26 | 3.30 | 3.30 |
278.23 | 3.39 | 3.39 |
282.30 | 3.07 | 3.07 |
350.29 | 4.09 | 4.09 |
350.40 | 4.57 | 4.57 |
317.27 | 4.18 | 4.18 |
340.40 | 2.70 | 2.70 |
457.59 | 4.96 | 4.96 |
430.48 | 2.15 | 2.15 |
249.27 | 3.16 | 3.16 |
249.27 | 3.16 | 3.16 |
267.26 | 3.30 | 3.30 |
349.41 | 4.60 | 4.60 |
363.44 | 4.91 | 4.91 |
352.42 | 2.90 | 2.90 |
267.26 | 3.30 | 3.30 |
303.16 | 4.05 | 4.05 |
312.17 | 4.22 | 4.22 |
298.29 | 3.00 | 3.00 |
336.26 | 4.01 | 4.01 |
368.46 | 3.48 | 3.48 |
466.47 | 4.08 | 4.08 |
429.54 | 4.18 | 4.18 |
359.45 | 3.32 | 3.32 |
335.40 | 4.27 | 4.27 |
337.38 | 3.12 | 3.12 |
424.57 | 5.05 | 5.05 |
285.71 | 4.25 | 4.25 |